SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 4,401.41 |
Enterprise Value ($M) | n/a |
Book Value ($M) | 558.19 |
Book Value / Share | 10.91 |
Price / Book | n/a |
NCAV ($M) | 234.17 |
NCAV / Share | 4.58 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.24 |
Return on Assets (ROA) | 0.21 |
Return on Equity (ROE) | 0.30 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.94 |
Current Ratio | 2.50 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 553.83 |
Assets | 877.85 |
Liabilities | 319.66 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
KLDO – Kaleido Biosciences, Inc. | KRBP – Kiromic BioPharma, Inc. |
KYKOF – Kyowa Kirin Co., Ltd. | LADX – LadRx Corporation |
LBTSF – Almirall, S.A. |
Financial data and stock pages provided by
Fintel.io